ABMED · GLOBAL REGULATORY & MARKET ACCESS

Global market access

38 international markets (countries and regional markets) in our service materials; each jurisdiction has its own requirements.

Find your target market

HSA

Singapore

Market access overview

HSA uses risk classes A–D. Class A product-registration exemption is distinct from SHARE product notification and dealer licensing; other devices use the applicable evaluation route.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

MDA

Malaysia

Market access overview

MDA registration, the local authorised representative, establishment licensing and applicable CAB conformity assessment are separate requirements. Determine class A–D and the eligible pathway.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Thai FDA

Thailand

Market access overview

Confirm the Thai FDA risk class, listing, notification or licensing route, local importer qualification and the applicable ASEAN dossier and Thai-language labelling.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Ministry of Health · Medical devices

Vietnam

Market access overview

Assess A/B declarations and C/D circulation registration separately under the applicable Vietnamese rules and transition arrangements. Use local classification and Vietnamese information.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

FDA Philippines

Philippines

Market access overview

Confirm the local establishment LTO and the applicable CMDN, CMDR or exemption route for the risk class and implementation stage. Maintain the authorised product scope.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Kemenkes

Indonesia

Market access overview

Assess class A–D, product grouping, a qualified local entity and the applicable circulation authorisation. Prepare technical evidence and Indonesian-language labelling.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

CDSCO

India

Market access overview

Under the Medical Devices Rules 2017, an authorised Indian agent normally applies on MD-14 for an MD-15 import licence. Assess specific exemptions and class A–D requirements individually.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

DRAP

Pakistan

Market access overview

DRAP distinguishes class A enlistment from class B–D registration. Establishment licensing, manufacturer authorisation and import responsibility must also be assessed.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

SFDA

Saudi Arabia

Market access overview

SFDA MDMA product authorisation, the overseas manufacturer’s authorised representative and importer/distributor licensing are distinct. Existing foreign approvals do not automatically authorise supply.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

EDE|Emirates Drug Establishment

United Arab Emirates

Market access overview

Use the Emirates Drug Establishment’s applicable marketing-authorisation service. Confirm registered MAH/manufacturing-site status and the qualified local marketing office or medical warehouse.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

INVIMA

Colombia

Market access overview

Assess INVIMA risk classification, product grouping and the applicable registration route. Define the registration holder and qualified importer roles separately.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

DIGEMID

Peru

Market access overview

Assess DIGEMID sanitary registration by device risk and product characteristics. Confirm local responsibility, Spanish documents and the applicable free-sale and authentication requirements.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

ANVISA

Brazil

Market access overview

ANVISA general devices use classes I–IV. Classes I/II generally follow notification and III/IV registration; assess the applicable BGMP/CBPF evidence and local holder separately.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

ANMAT

Argentina

Market access overview

Assess the current ANMAT risk-based registration and any eligible simplified route. Confirm the qualified local applicant/importer and Spanish-language evidence.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

ISP / ANDIM

Chile

Market access overview

Check the ISP/ANDIM controlled-product scope and implementation stage before deciding whether sanitary registration applies. Registration, import clearance and use/distribution procedures are distinct.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

ARCSA

Ecuador

Market access overview

Use the applicable ARCSA medical-device framework. Confirm risk class, ordinary or eligible simplified registration, the authorised local applicant and Spanish information.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Health Canada

Canada

Market access overview

Class I generally does not require an MDL, while establishment MDEL obligations must still be assessed. Classes II–IV require the applicable MDL and MDSAP quality evidence.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

COFEPRIS

Mexico

Market access overview

Assess COFEPRIS classification and the currently available ordinary or reliance route for the specific product. Foreign approvals or free-sale certificates do not automatically establish Mexican acceptance.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

FDA

United States

Market access overview

FDA device classification and product code determine whether exemption, 510(k), De Novo or PMA applies. Establishment registration and listing do not constitute FDA approval.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Ministry of Health

Costa Rica

Market access overview

Assess the EMB category and risk class under Costa Rica’s applicable framework, local applicant responsibility, Spanish evidence and the registration/import arrangements.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

European Commission / national competent authorities

European Union

Market access overview

Apply MDR for general medical devices and IVDR for IVDs. Determine classification, conformity assessment, technical and clinical/performance evidence, EU-REP, PRRC and applicable UDI/EUDAMED obligations.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

MHRA

United Kingdom

Market access overview

Distinguish Great Britain from Northern Ireland. Check the eligible UKCA or recognised CE route, the UKRP and MHRA registration; registration is not itself comprehensive product approval.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Swissmedic

Switzerland

Market access overview

Swiss MedDO/IvDO requirements, applicable conformity evidence, CH-REP, importer responsibilities and swissdamed obligations are distinct from EU procedures.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

TİTCK

Türkiye

Market access overview

Confirm the Turkish device/IVD framework, the applicable local representative and establishment roles, Turkish information and ÜTS product and traceability requirements.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Ministry of Health / NDDA

Kazakhstan

Market access overview

Kazakhstan is geographically in Central Asia and is also an EAEU member. Distinguish national registration from the EAEU route, territorial coverage and current transition conditions.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Ministry of Health / national review authority

Uzbekistan

Market access overview

Confirm Uzbekistan’s applicable national registration procedure, local authorised responsibility, technical evidence and any testing. An EAEU certificate does not automatically replace Uzbek registration.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Roszdravnadzor

Russia

Market access overview

Distinguish the Russian national and EAEU routes, intended sales territory and current transition arrangements. Assess Russian evidence, testing and applicable QMS inspections.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Ministry of Health / EAEU authorities

Belarus

Market access overview

Distinguish Belarusian national registration from the EAEU route. Confirm representative responsibility, the certificate territory, evidence and current transition conditions.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

MFDS / designated bodies

South Korea

Market access overview

MFDS uses classes I–IV with notification, certification or approval as applicable. Confirm the importer’s licence, the technical-review route and applicable KGMP evidence individually.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

PMDA / MHLW

Japan

Market access overview

Confirm JMDN, class and the notification, third-party certification or approval route under the PMD Act. Assess the Japanese MAH/D-MAH, foreign-manufacturer registration and QMS responsibilities.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

SAHPRA

South Africa

Market access overview

Distinguish SAHPRA establishment licensing from product registration and the currently applicable call-up/implementation scope. Assess local responsibility and appropriate quality-system evidence.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

EDA

Egypt

Market access overview

Assess the EDA route by device/IVD category, available reference evidence and current guidance. Confirm the qualified local entity, registration and import procedures.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

PPB

Kenya

Market access overview

Assess the PPB device/IVD class A–D requirements, product grouping and qualified local applicant. Registration and import permission must be considered separately.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

NAFDAC

Nigeria

Market access overview

Assess NAFDAC’s applicable device/IVD registration, grouping, local applicant, labelling and evidence requirements. Samples, testing or inspection depend on the product and route.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

TFDA

Taiwan

Market access overview

Assess TFDA class I/II/III, the applicable listing or registration route, local medical-device dealer and manufacturing-site QSD requirements. Mainland-origin imports require separate trade-scope checks.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Department of Health · MDD

Hong Kong

Market access overview

Confirm the applicable MDACS voluntary listing route and Hong Kong Local Responsible Person. Do not present proposed statutory regulation as if all devices already require mandatory registration.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Medsafe

New Zealand

Market access overview

WAND is a notification database, not a product approval. Assess device scope and exemptions, the actual New Zealand Sponsor and the applicable notification and maintenance duties.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

TGA

Australia

Market access overview

Assess device or IVD classification, exemptions and the applicable ARTG inclusion route. Australian Sponsor responsibility, manufacturer conformity evidence and application audit are separate matters.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Based on the regulatory section of ABMED’s 38-market report, with source material dated 17 November 2026. Confirm current rules and the specific product before implementation. Market coverage does not imply a company office in every market.